This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Hepatitis B, Diphtheria, Haemophilus Influenzae Type b (Hib), Poliomyelitis, Pertussis or Tetanus
and you are
between 12 and 16
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This study will assess the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals' (formerly SB Biologicals') DTPa-HBV-IPV/Hib (Infanrix hexa™) vaccine compared with separate administration of DTPa-HBV-IPV (Infanrix penta™) and Hib (Hiberix™) vaccine administered at 3, 5 and 11 (or 12) months of age.

Provided treatments

  • Biological: DTPa-HBV-IPV/Hib (Infanrix hexa™)
  • Biological: DTPa-HBV-IPV (Infanrix penta™)
  • Biological: Hib (Hiberix™)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01457508. The sponsor of the trial is GlaxoSmithKline and it is looking for 440 volunteers for the current phase.
Official trial title:
Study to Assess the Immunogenicity and Reactogenicity of DTPa-HBV-IPV Vaccine Mixed With Hib Vaccine to Healthy Infants at 3, 5 and 11 Months of Age, Compared to Each Vaccine Administered Separately